Effect of EGFR Mutations on Survival in Patients following Surgical Resection of Lung Adenocarcinoma

被引:0
作者
Laidlaw, Grace [1 ]
Gao, Rebecca [1 ]
Ayers, Kelsey [2 ]
Backhus, Leah [2 ]
Berry, Mark [2 ]
Shrager, Joseph [2 ]
机构
[1] Stanford Univ, Sch Med, Stanford, CA 94305 USA
[2] Stanford Univ, Sch Med, Cardiothorac Surg, Stanford, CA 94305 USA
关键词
EGFR; lung adenocarcinoma; sublobar resection;
D O I
10.1016/j.jtho.2016.11.1000
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
P1.08-033
引用
收藏
页码:S751 / S751
页数:1
相关论文
共 50 条
  • [21] Primary Tumor Resection Improves Survival for EGFR-TKI-Treated Patients With Occult M1a Lung Adenocarcinoma
    Fu, Fangqiu
    Wen, Zhexu
    Gao, Zhendong
    Zhao, Yue
    Li, Yuan
    Zhang, Yang
    Chen, Haiquan
    FRONTIERS IN ONCOLOGY, 2021, 11
  • [22] EGFR Mutation Status as a Prognostic Marker in Stage 1 Lung Adenocarcinoma After Definitive Surgical Resection
    Galvez, C.
    Jacob, S.
    Zhao, J.
    Tegtmeyer, K.
    Finkelman, B.
    Chae, Y. K.
    Mohindra, N.
    Jovanovic, B.
    Behdad, A.
    Villaflor, V.
    JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (10) : S433 - S433
  • [23] EGFR Mutations in US Hispanics with Lung Adenocarcinoma are Common and Portend a Worse Prognosis
    Villena-Vargas, J.
    Mynard, N.
    Voza, F.
    Nasar, A.
    Chow, O.
    Lee, B.
    Harrison, S.
    Stiles, B.
    Port, J.
    Altorki, N.
    JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (03) : S443 - S444
  • [24] Concurrent EGFR and KRAS Mutations in Lung Adenocarcinoma: A Single Institution Case Series
    Schwartz, C.
    Khan, M.
    Nguyen, R.
    Pasquinelli, M.
    Feldman, L.
    JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (03) : S600 - S601
  • [25] Omental metastatic adenocarcinoma from lung cancer with EGFR mutations: a case report
    Zhu, Yan-Mei
    Li, Qiang
    Qu, Ning
    Zhao, Peng
    Gao, Xiao-Zhuo
    Zhang, Lin-Lin
    Zhang, Yong
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2018, 11 (06): : 6276 - 6282
  • [26] Molecular Characterization of EGFR Somatic Mutations in Lung Adenocarcinoma Tumors from Chilean Patients
    Sepulveda-Hermosilla, G.
    Blanco, A.
    Lizana, R.
    Ramos, L.
    Freire, M.
    Spencer, M.
    Chernilo, S.
    Aren, O.
    Perez, P.
    Armisen, R.
    JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (09) : S157 - S157
  • [27] EGFR and KRAS Mutations in the Non-Tumoral Lung. Prognosis in Patients with Adenocarcinoma
    Chalela, Roberto
    Bellosillo, Beatriz
    Curull, Victor
    Longaron, Raquel
    Pascual-Guardia, Sergi
    Badenes-Bonet, Diana
    Arriola, Edurne
    Sanchez-Font, Albert
    Pijuan, Lara
    Gea, Joaquim
    JOURNAL OF CLINICAL MEDICINE, 2019, 8 (04)
  • [28] Monitoring of carcinoembryonic antigen levels is predictive of EGFR mutations and efficacy of EGFR-TKI in patients with lung adenocarcinoma
    Zhang, Yanwei
    Jin, Bo
    Shao, Minhua
    Dong, Yu
    Lou, Yuqing
    Huang, Aimi
    Han, Baohui
    TUMOR BIOLOGY, 2014, 35 (05) : 4921 - 4928
  • [29] Prognostic Impact of EGFR Mutation in Patients with Surgically Resected Lung Adenocarcinoma; Analysis about Subtypes of EGFR Mutations
    Kawaguchi, Yohei
    Okano, Tetsuya
    Imai, Ken Taro
    Maehara, Sachio
    Junichi, Maeda
    Yoshida, Koichi
    Hagiwara, Masaru
    Kakihana, Masatoshi
    Kajiwara, Naohiro
    Ohira, Tatsuo
    Ikeda, Norihiko
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (01) : S751 - S752
  • [30] EGFR-TKI Alone or with Concomitant Radiotherapy for Brain Metastases in Lung Adenocarcinoma Patients with EGFR Gene Mutations
    Chen, Yongshun
    Yang, Jing
    Li, Xue
    Hao, Daxuan
    Wu, Xiaoyuan
    Yang, Yuanyuan
    Hu, Xiaona
    He, Chunyu
    Wang, Wen
    Liu, Jinsong
    Wang, Jianhua
    JOURNAL OF THORACIC ONCOLOGY, 2015, 10 (09) : S278 - S278